HeartValveSurgery.com, a outstanding coronary heart well being instructional useful resource and on-line group for sufferers, lately featured cardiac surgeon Joanna Chikwe, MD, chair of the Division of Cardiac Surgical procedure on the Smidt Heart Institute, in a webinar. Throughout the occasion, which garnered a document variety of attendees for the platform, Chikwe reviewed the most recent in COVID-19 analysis and the way the illness impacts the center.
Chikwe, who makes a speciality of coronary heart valve surgical procedure, highlighted a current Cedars-Sinai study, which discovered that the novel coronavirus might be able to immediately infect the center’s cells. Printed in Cell Studies Drugs, the analysis confirmed that coronary heart muscle cells in a lab dish revealed adjustments of their capability to beat after 72 hours of an infection.
Throughout the webinar, Chikwe additionally mentioned how sufferers can finest handle coronary heart valve illness throughout COVID-19, in addition to security protocols Cedars-Sinai has enacted. She urged sufferers to maintain taking their prescribed drugs through the pandemic and to not delay care as a result of their coronary heart situation might worsen.
“It’s actually price highlighting that valve illness is progressive, it is not static,” Chikwe stated.
Sufferers shouldn’t keep away from needed in-person doctor appointments for concern of catching the virus, Chikwe stated, as a result of delaying remedy for coronary heart illness is extra harmful.
“Hospitals have applied large, large adjustments to actually enhance security and decrease your threat. Don’t wait to see your physician,” Chikwe stated. “COVID – if we take the best precautions – poses comparatively low threat to most sufferers. Ready for coronary heart surgical procedure poses a probably larger threat.”
Click here to look at the entire webinar from HeartValveSurgery.com.
